aluates Reports

$ 0.0

Automative

Global Retinal Dystrophy Treatment Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-16K5871

Global Retinal Dystrophy Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Retinal Dystrophy Treatment Market Research Report 2025

Code: QYRE-Auto-16K5871

Report

June 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Spark Therapeutics (Roche)

Novartis

GlaxoSmithKline PLC

Applied Genetic Technologies Corporation

Oxford BioMedica

Biogen

HORAMA S.A.

MeiraGTx Limited

Novelion Therapeutics

IVERIC bio

Reflection Biotechnologies

Retinal Dystrophy Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Retinal Dystrophy Treatment Market

The global market for Retinal Dystrophy Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Retinal Dystrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Dystrophy Treatment.

The Retinal Dystrophy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Retinal Dystrophy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Retinal Dystrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Retinal Dystrophy Treatment Market Report

Report Metric	Details
Report Name	Retinal Dystrophy Treatment Market
CAGR	5%
Segment by Type	Gene Therapy Treatment Symptomatic Treatment
Segment by Application	Hospitals Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Spark Therapeutics (Roche), Novartis AG, GlaxoSmithKline, Applied Genetic Technologies Corporation, Oxford BioMedica, Biogen, HORAMA S.A., MeiraGTx Limited, Novelion Therapeutics, IVERIC bio, Reflection Biotechnologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retinal Dystrophy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Retinal Dystrophy Treatment Market report?

Ans: The main players in the Retinal Dystrophy Treatment Market are Spark Therapeutics (Roche), Novartis AG, GlaxoSmithKline, Applied Genetic Technologies Corporation, Oxford BioMedica, Biogen, HORAMA S.A., MeiraGTx Limited, Novelion Therapeutics, IVERIC bio, Reflection Biotechnologies

What are the Application segmentation covered in the Retinal Dystrophy Treatment Market report?

Ans: The Applications covered in the Retinal Dystrophy Treatment Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Retinal Dystrophy Treatment Market report?

Ans: The Types covered in the Retinal Dystrophy Treatment Market report are Gene Therapy Treatment, Symptomatic Treatment

Recommended Reports

Ophthalmic & Retinal Treatments

Ophthalmology Pharmaceuticals

Neuro & Muscular Disease Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Retinal Dystrophy Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gene Therapy Treatment

1.2.3 Symptomatic Treatment

1.3 Market by Application

1.3.1 Global Retinal Dystrophy Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Retinal Dystrophy Treatment Market Perspective (2020-2031)

2.2 Global Retinal Dystrophy Treatment Growth Trends by Region

2.2.1 Global Retinal Dystrophy Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Retinal Dystrophy Treatment Historic Market Size by Region (2020-2025)

2.2.3 Retinal Dystrophy Treatment Forecasted Market Size by Region (2026-2031)

2.3 Retinal Dystrophy Treatment Market Dynamics

2.3.1 Retinal Dystrophy Treatment Industry Trends

2.3.2 Retinal Dystrophy Treatment Market Drivers

2.3.3 Retinal Dystrophy Treatment Market Challenges

2.3.4 Retinal Dystrophy Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Retinal Dystrophy Treatment Players by Revenue

3.1.1 Global Top Retinal Dystrophy Treatment Players by Revenue (2020-2025)

3.1.2 Global Retinal Dystrophy Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Retinal Dystrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Retinal Dystrophy Treatment Revenue

3.4 Global Retinal Dystrophy Treatment Market Concentration Ratio

3.4.1 Global Retinal Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Retinal Dystrophy Treatment Revenue in 2024

3.5 Global Key Players of Retinal Dystrophy Treatment Head office and Area Served

3.6 Global Key Players of Retinal Dystrophy Treatment, Product and Application

3.7 Global Key Players of Retinal Dystrophy Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Retinal Dystrophy Treatment Breakdown Data by Type

4.1 Global Retinal Dystrophy Treatment Historic Market Size by Type (2020-2025)

4.2 Global Retinal Dystrophy Treatment Forecasted Market Size by Type (2026-2031)

5 Retinal Dystrophy Treatment Breakdown Data by Application

5.1 Global Retinal Dystrophy Treatment Historic Market Size by Application (2020-2025)

5.2 Global Retinal Dystrophy Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Retinal Dystrophy Treatment Market Size (2020-2031)

6.2 North America Retinal Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Retinal Dystrophy Treatment Market Size by Country (2020-2025)

6.4 North America Retinal Dystrophy Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Retinal Dystrophy Treatment Market Size (2020-2031)

7.2 Europe Retinal Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Retinal Dystrophy Treatment Market Size by Country (2020-2025)

7.4 Europe Retinal Dystrophy Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Retinal Dystrophy Treatment Market Size (2020-2031)

8.2 Asia-Pacific Retinal Dystrophy Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Retinal Dystrophy Treatment Market Size (2020-2031)

9.2 Latin America Retinal Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Retinal Dystrophy Treatment Market Size by Country (2020-2025)

9.4 Latin America Retinal Dystrophy Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Retinal Dystrophy Treatment Market Size (2020-2031)

10.2 Middle East & Africa Retinal Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Spark Therapeutics (Roche)

11.1.1 Spark Therapeutics (Roche) Company Details

11.1.2 Spark Therapeutics (Roche) Business Overview

11.1.3 Spark Therapeutics (Roche) Retinal Dystrophy Treatment Introduction

11.1.4 Spark Therapeutics (Roche) Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.1.5 Spark Therapeutics (Roche) Recent Development

11.2 Novartis AG

11.2.1 Novartis AG Company Details

11.2.2 Novartis AG Business Overview

11.2.3 Novartis AG Retinal Dystrophy Treatment Introduction

11.2.4 Novartis AG Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.2.5 Novartis AG Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Retinal Dystrophy Treatment Introduction

11.3.4 GlaxoSmithKline Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.3.5 GlaxoSmithKline Recent Development

11.4 Applied Genetic Technologies Corporation

11.4.1 Applied Genetic Technologies Corporation Company Details

11.4.2 Applied Genetic Technologies Corporation Business Overview

11.4.3 Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Introduction

11.4.4 Applied Genetic Technologies Corporation Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.4.5 Applied Genetic Technologies Corporation Recent Development

11.5 Oxford BioMedica

11.5.1 Oxford BioMedica Company Details

11.5.2 Oxford BioMedica Business Overview

11.5.3 Oxford BioMedica Retinal Dystrophy Treatment Introduction

11.5.4 Oxford BioMedica Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.5.5 Oxford BioMedica Recent Development

11.6 Biogen

11.6.1 Biogen Company Details

11.6.2 Biogen Business Overview

11.6.3 Biogen Retinal Dystrophy Treatment Introduction

11.6.4 Biogen Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.6.5 Biogen Recent Development

11.7 HORAMA S.A.

11.7.1 HORAMA S.A. Company Details

11.7.2 HORAMA S.A. Business Overview

11.7.3 HORAMA S.A. Retinal Dystrophy Treatment Introduction

11.7.4 HORAMA S.A. Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.7.5 HORAMA S.A. Recent Development

11.8 MeiraGTx Limited

11.8.1 MeiraGTx Limited Company Details

11.8.2 MeiraGTx Limited Business Overview

11.8.3 MeiraGTx Limited Retinal Dystrophy Treatment Introduction

11.8.4 MeiraGTx Limited Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.8.5 MeiraGTx Limited Recent Development

11.9 Novelion Therapeutics

11.9.1 Novelion Therapeutics Company Details

11.9.2 Novelion Therapeutics Business Overview

11.9.3 Novelion Therapeutics Retinal Dystrophy Treatment Introduction

11.9.4 Novelion Therapeutics Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.9.5 Novelion Therapeutics Recent Development

11.10 IVERIC bio

11.10.1 IVERIC bio Company Details

11.10.2 IVERIC bio Business Overview

11.10.3 IVERIC bio Retinal Dystrophy Treatment Introduction

11.10.4 IVERIC bio Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.10.5 IVERIC bio Recent Development

11.11 Reflection Biotechnologies

11.11.1 Reflection Biotechnologies Company Details

11.11.2 Reflection Biotechnologies Business Overview

11.11.3 Reflection Biotechnologies Retinal Dystrophy Treatment Introduction

11.11.4 Reflection Biotechnologies Revenue in Retinal Dystrophy Treatment Business (2020-2025)

11.11.5 Reflection Biotechnologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Spark Therapeutics (Roche)

Novartis

GlaxoSmithKline PLC

Applied Genetic Technologies Corporation

Oxford BioMedica

Biogen

HORAMA S.A.

MeiraGTx Limited

Novelion Therapeutics

IVERIC bio

Reflection Biotechnologies

List of Tables

Table 1. Global Retinal Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gene Therapy Treatment

Table 3. Key Players of Symptomatic Treatment

Table 4. Global Retinal Dystrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Retinal Dystrophy Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Retinal Dystrophy Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Retinal Dystrophy Treatment Market Share by Region (2020-2025)

Table 8. Global Retinal Dystrophy Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Retinal Dystrophy Treatment Market Share by Region (2026-2031)

Table 10. Retinal Dystrophy Treatment Market Trends

Table 11. Retinal Dystrophy Treatment Market Drivers

Table 12. Retinal Dystrophy Treatment Market Challenges

Table 13. Retinal Dystrophy Treatment Market Restraints

Table 14. Global Retinal Dystrophy Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Retinal Dystrophy Treatment Market Share by Players (2020-2025)

Table 16. Global Top Retinal Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Dystrophy Treatment as of 2024)

Table 17. Ranking of Global Top Retinal Dystrophy Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Retinal Dystrophy Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Retinal Dystrophy Treatment, Headquarters and Area Served

Table 20. Global Key Players of Retinal Dystrophy Treatment, Product and Application

Table 21. Global Key Players of Retinal Dystrophy Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Retinal Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Retinal Dystrophy Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Retinal Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Retinal Dystrophy Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Retinal Dystrophy Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Retinal Dystrophy Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Retinal Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Retinal Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Retinal Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Retinal Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Retinal Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Retinal Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Retinal Dystrophy Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Retinal Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Retinal Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Retinal Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Retinal Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Spark Therapeutics (Roche) Company Details

Table 47. Spark Therapeutics (Roche) Business Overview

Table 48. Spark Therapeutics (Roche) Retinal Dystrophy Treatment Product

Table 49. Spark Therapeutics (Roche) Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 50. Spark Therapeutics (Roche) Recent Development

Table 51. Novartis AG Company Details

Table 52. Novartis AG Business Overview

Table 53. Novartis AG Retinal Dystrophy Treatment Product

Table 54. Novartis AG Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 55. Novartis AG Recent Development

Table 56. GlaxoSmithKline Company Details

Table 57. GlaxoSmithKline Business Overview

Table 58. GlaxoSmithKline Retinal Dystrophy Treatment Product

Table 59. GlaxoSmithKline Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 60. GlaxoSmithKline Recent Development

Table 61. Applied Genetic Technologies Corporation Company Details

Table 62. Applied Genetic Technologies Corporation Business Overview

Table 63. Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Product

Table 64. Applied Genetic Technologies Corporation Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 65. Applied Genetic Technologies Corporation Recent Development

Table 66. Oxford BioMedica Company Details

Table 67. Oxford BioMedica Business Overview

Table 68. Oxford BioMedica Retinal Dystrophy Treatment Product

Table 69. Oxford BioMedica Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 70. Oxford BioMedica Recent Development

Table 71. Biogen Company Details

Table 72. Biogen Business Overview

Table 73. Biogen Retinal Dystrophy Treatment Product

Table 74. Biogen Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 75. Biogen Recent Development

Table 76. HORAMA S.A. Company Details

Table 77. HORAMA S.A. Business Overview

Table 78. HORAMA S.A. Retinal Dystrophy Treatment Product

Table 79. HORAMA S.A. Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 80. HORAMA S.A. Recent Development

Table 81. MeiraGTx Limited Company Details

Table 82. MeiraGTx Limited Business Overview

Table 83. MeiraGTx Limited Retinal Dystrophy Treatment Product

Table 84. MeiraGTx Limited Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 85. MeiraGTx Limited Recent Development

Table 86. Novelion Therapeutics Company Details

Table 87. Novelion Therapeutics Business Overview

Table 88. Novelion Therapeutics Retinal Dystrophy Treatment Product

Table 89. Novelion Therapeutics Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 90. Novelion Therapeutics Recent Development

Table 91. IVERIC bio Company Details

Table 92. IVERIC bio Business Overview

Table 93. IVERIC bio Retinal Dystrophy Treatment Product

Table 94. IVERIC bio Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 95. IVERIC bio Recent Development

Table 96. Reflection Biotechnologies Company Details

Table 97. Reflection Biotechnologies Business Overview

Table 98. Reflection Biotechnologies Retinal Dystrophy Treatment Product

Table 99. Reflection Biotechnologies Revenue in Retinal Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 100. Reflection Biotechnologies Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Retinal Dystrophy Treatment Picture

Figure 2. Global Retinal Dystrophy Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Retinal Dystrophy Treatment Market Share by Type: 2024 VS 2031

Figure 4. Gene Therapy Treatment Features

Figure 5. Symptomatic Treatment Features

Figure 6. Global Retinal Dystrophy Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Retinal Dystrophy Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Specialty Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Retinal Dystrophy Treatment Report Years Considered

Figure 12. Global Retinal Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Retinal Dystrophy Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Retinal Dystrophy Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Retinal Dystrophy Treatment Market Share by Players in 2024

Figure 16. Global Top Retinal Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Dystrophy Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Retinal Dystrophy Treatment Revenue in 2024

Figure 18. North America Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Retinal Dystrophy Treatment Market Share by Country (2020-2031)

Figure 20. United States Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Retinal Dystrophy Treatment Market Share by Country (2020-2031)

Figure 24. Germany Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Retinal Dystrophy Treatment Market Share by Region (2020-2031)

Figure 32. China Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Retinal Dystrophy Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Retinal Dystrophy Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Retinal Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Spark Therapeutics (Roche) Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 48. Novartis AG Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 50. Applied Genetic Technologies Corporation Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 51. Oxford BioMedica Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 52. Biogen Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 53. HORAMA S.A. Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 54. MeiraGTx Limited Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 55. Novelion Therapeutics Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 56. IVERIC bio Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 57. Reflection Biotechnologies Revenue Growth Rate in Retinal Dystrophy Treatment Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Retinal Disorder Treatment Market Research Report 2024

Global Retinitis Pigmentosa Treatment Market Research Report 2024

Retinal Detachment Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report 2024

Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Amblyopia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Eye Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Macular Degeneration Drug Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Retinoid Treatment for Skin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinopathy Of Prematurity Therapeutics Market Research Report 2024

Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Juvenile Macular Degeneration Treatment Market Research Report 2024

Duchenne Muscular Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ischemic Optic Neuropathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Uveitis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions